Targeting Synthetic Lethality, Insilico Medicine Nominates WRN Small Molecule Pre-Clinical Candidate for MSI-H Cancers (IMAGE)

InSilico Medicine

Targeting Synthetic Lethality, Insilico Medicine Nominates WRN Small Molecule Pre-Clinical Candidate for MSI-H Cancers

Caption

ISM2196 is a novel, potent WRN inhibitor, designed with the assistance of Alchemistry, one of the latest modules of Chemistry 42.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.